Clinical Trials

Colorectal Neoplasms

NCT04302025 2026-05-22

NAUTIKA1

99 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04570423 2026-05-22

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

40 enrolled

Lymphoid

Lymphoma

NCT05981703 2026-05-22

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

217 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06803680 2026-05-22

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

90 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07419295 2026-05-22

TroFuse-031

590 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07602140 2026-05-22

TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study.

40 enrolled

Phase EARLY_PHASE1 Recruiting

Gastric Cancer With Liver Metastases

NCT03594630 2026-05-20

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

120 enrolled

Phase 2 Active not recruiting

Rectal Neoplasms

NCT04015778 2026-05-20

A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China

316 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07162506 2026-05-19

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

120 enrolled

Esophageal Neoplasms

NCT07595172 2026-05-19

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Phase 1/2 Recruiting

55 enrolled

789 enrolled 32 charts 1 FDA

Pancreatic Neoplasms

NCT03409614 2026-05-18

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT05255653 2026-05-15

RAINBO

Phase 2/3 Recruiting

1,615 enrolled

Gynecologic

Endometrial Neoplasms

NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

294 enrolled

Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

NCT03570892 2026-05-14

BELINDA

Phase 3 Completed

330 enrolled 10 charts

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05834413 2026-05-13

Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

Phase NA Recruiting

367 enrolled

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07391774 2026-05-13

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

1,978 enrolled

Breast

Anatomic Stage II Breast Cancer AJCC v8

NCT07454226 2026-05-13

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

Phase NA Recruiting

92 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07583303 2026-05-13

BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

Phase 1 Not yet recruiting

19 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03930498 2026-05-11

Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma

Phase 2 Active not recruiting

68 enrolled

Nasopharyngeal Carcinoma

NCT05340491 2026-05-11

Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

212 enrolled

Phase 3 Active not recruiting

Nasopharyngeal Carcinoma

NCT05780372 2026-05-11

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

474 enrolled

Nasopharyngeal Carcinoma

NCT05941741 2026-05-11

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

380 enrolled

Nasopharyngeal Carcinoma

NCT07188532 2026-05-11

BEAR

Phase NA Recruiting

141 enrolled

Sarcoma

Sarcoma, Ewing

NCT05673148 2026-05-08

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

364 enrolled

Colorectal Neoplasms

NCT06195189 2026-05-08

WU-KONG36

Phase 1/2 Recruiting

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06431685 2026-05-08

Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

10 enrolled

CNS

Meningeal Carcinomatosis

NCT07000253 2026-05-07

OMEC-5

Phase 2/3 Recruiting

290 enrolled

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT07573696 2026-05-07

Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and Chemotherapy

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06800339 2026-05-06

NEORADJUVANT

18 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05710328 2026-05-05

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

235 enrolled

Breast

Anatomic Stage II Breast Cancer AJCC v8

NCT07258147 2026-05-05

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

30 enrolled

Lung Neoplasms

NCT07454720 2026-05-05

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Phase 2/3 Recruiting

165 enrolled

Locally Advanced Resectable Rectal Cancer

NCT07567326 2026-05-05

Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLC

78 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06177067 2026-05-04

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Other hematologic neoplasm

24 enrolled

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT07565532 2026-05-04

Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment

Recruiting

500 enrolled

Small Cell Lung Carcinoma

NCT07565974 2026-05-04

THC Versus THC/CBD Versus Placebo to Improve Sleep Quality for Patients With Solid Organ Cancer and Insomnia

69 enrolled

Sleep Initiation and Maintenance Disorders

NCT06578247 2026-04-30

QuANTUM-WILD

Other hematologic neoplasm

700 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT07556848 2026-04-30

A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer

Phase 3 Not yet recruiting

356 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06477523 2026-04-29

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Phase 1/2 Active not recruiting

57 enrolled

SCLC, Extensive Stage

NCT07549061 2026-04-29

Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC

19 enrolled

Lung Neoplasms

NCT07555678 2026-04-29

Chase

241 enrolled

Anus Neoplasms

NCT06844422 2026-04-28

Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)

Phase 1/2 Recruiting

37 enrolled

Pancreatic Neoplasms

NCT07381309 2026-04-28

VVSHIP

114 enrolled

CRC

NCT06402708 2026-04-27

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

172 enrolled

Phase NA Not yet recruiting

Thymoma

NCT07552402 2026-04-27

FREEDOM

150 enrolled

Phase 2 Enrolling by invitation

Stomach Neoplasms

NCT07542262 2026-04-24

NIVO402025

128 enrolled

Stomach Neoplasms, Colorectal Neoplasms

NCT06576921 2026-04-23

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

116 enrolled

Stomach Neoplasms

NCT06767007 2026-04-23

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

31 enrolled